Last price paid | 0.30 | |
Change | +11.11% [ +0.03 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 19.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +52.50% |
Year to date (YTD) | -26.83% |
1 month | +3.45% |
3 months | +3.45% |
1 year | +7.14% |
3 years | n.a. |
Issue price | 0.20 |
Underlying price on issue | 46.20 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250732984 |
Symbol | IBSNMZ |
Security | 125073298 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 53.888300 |
Stop-loss level | 51.815100 |
Distance to stop-loss level | 29.86% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 3.16% |
Premium p.a. | n.a. |
Leverage | 2.62 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 13.988300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 265.00 |
NOVARTIS N | 96.34 |
LOGITECH INT. | 80.58 |
Givaudan | 4'306.00 |
Swiss Life Hldg | 678.40 |
Name | Price |
---|---|
Swiss Re | 106.15 |
ZURICH INSURANCE | 474.30 |
ROCHE GS | 279.60 |
Alcon AG | 80.42 |
SWISSCOM N | 535.00 |